These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 6890359

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Minaprine, a new drug with antidepressant properties.
    Bizière K, Worms P, Kan JP, Mandel P, Garattini S, Roncucci R.
    Drugs Exp Clin Res; 1985; 11(12):831-40. PubMed ID: 3836113
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [The new versus the old antidepressant drugs: a comparative study of their psychopharmacological profiles (author's transl)].
    Bourin M, Puech AJ, Chermat R, Doare L, Poncelet M, Simon P.
    Encephale; 1981; 7(3):235-42. PubMed ID: 7285851
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cholinomimetic activities of minaprine.
    Worms P, Kan JP, Steinberg R, Terranova JP, Perio A, Biziere K.
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):411-8. PubMed ID: 2586634
    [Abstract] [Full Text] [Related]

  • 11. Minaprine, but not oxiracetam, prevents desipramine-induced impairment of avoidance learning in mice.
    Sansone M, Battaglia M, Vetulani J.
    Pol J Pharmacol; 1995 Oct; 47(1):69-73. PubMed ID: 7550552
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Amoxapine in experimental psychopharmacology: a neuroleptic or an antidepressant?
    Chermat R, Simon P, Boissier JR.
    Arzneimittelforschung; 1979 Oct; 29(5):814-20. PubMed ID: 40575
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. In vivo characterization of T-794, a novel reversible inhibitor of monoamine oxidase-A, as an antidepressant with a wide safety margin.
    Kato M, Katayama T, Iwata H, Yamamura M, Matsuoka Y, Narita H.
    J Pharmacol Exp Ther; 1998 Mar; 284(3):983-90. PubMed ID: 9495858
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacological profile of the novel antidepressant 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno-[2,3-d]pyrimidine monohydrate hydrochloride.
    Eguchi J, Inomata Y, Yuasa T, Egawa M, Saito K.
    Arzneimittelforschung; 1997 Dec; 47(12):1337-47. PubMed ID: 9450161
    [Abstract] [Full Text] [Related]

  • 19. [Comparative pharmacological study of a series of new antidepressants].
    Mashkovskiĭ MD, Andreeva NI.
    Farmakol Toksikol; 1981 Dec; 44(6):698-702. PubMed ID: 6975726
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacological profile of reboxetine, a representative of new class of antidepressant drugs, selective noradrenaline reuptake inhibitor (NARI), given acutely.
    Rogóz Z, Wróbel A, Krasicka-Domka M, Maj J.
    Pol J Pharmacol; 1999 Dec; 51(5):399-404. PubMed ID: 10817540
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.